- New Models: Community Pharmacy s Role in an ACO!
|
|
|
- Posy Small
- 8 years ago
- Views:
Transcription
1 - New Models: Community Pharmacy s Role in an ACO! - Bruce Thompson, RPh, MS" - Director of Health System Pharmacy Services" - Hennepin County Medical Center" 1 Objectives q Realize the benefits Pharmacy provides with outcome data." - Know the barriers Community Pharmacy needs to overcome to be a viable member of health system Realize the current barriers and opportunities in transition of care." Understand the opportunities for pharmacy in an ACO model." Bed Hospital DSH/Trauma Center. 60 Clinics Primary Care, Specialty 2400 RX per day 20 RPh provide MTM Services 3 1
2 It is Estimated That - More than 2 Million individuals in the United States take Warfarin - Over 24 Million prescriptions are dispensed each year - How many prescriptions do you dispense each year? 4 How do you monitor Warfarin Patients - How many patients do you know have had an INR within the last 4 weeks?" - How many patients do you know that the INR is in range for their therapy? " 5 Patient Case A patient with a history of atrial fibrillation is admitted to the hospital. The patient has been receiving: " Warfarin 5mg every day for the past six months. The INR is high so the doctor writes a new prescription for the patient at discharge and explains that the new prescription is Warfarin 3mg only for Tuesday, Thursday and Saturday; (continue to take 5mg the other days)." 6 2
3 Patient Case Result #1 - Upon discharge the hospital gives the patient the discharge prescriptions, asks if they understand what is needed and discharges the patient. Within the pages it instructs the patient to make an appointment with the anticoagulation clinic within 3-5 days" - The patient fills the prescription at their regular community pharmacy. The patient now takes the Warfarin 5mg every day and Warfarin 3mg on Tuesdays, Thursday and Saturdays. Thus 8mg three days a week." - Minimal interaction with the pharmacist." 7 Patient Case Result #1 - Ten days later, the patient has not gone to the anticoagulation clinic and presents at the Emergency Department with multiple bruises, nose bleeds and coughing blood." - His blood level is 3 times the safe level. The patient is given platelets, packed cells and an antidote for the warfarin overdose." - Patient is hospitalized for 8 additional days and survives. " " 8 Patient Case #2 - Upon discharge the hospital coordinates care with the anticoagulation clinic and the community pharmacy. Since this is a medication on the High Risk protocol, the pharmacist provides the patient education, explains the complex treatment and provides the patient with a calendar to assist taking the medications correctly." - Follow-up appointments are made for the patient and confirmed with the patient before they leave." 9 3
4 Patient Case #2 - Patient understands the importance of the medication regimen" - Patient receives follow up care at the anticoagulation clinic 5 days post discharge." - The community pharmacy has open access to the patient s medical record to ensure the best therapy." - No Hospitalizations or ED visits in the following 6 months." 10 What is the relationship between you and your Health System? Community Pharmacy Hospital Home Care SNF Clinics Dispensing without MTM Med Rec ( If accurate) Transistions without MTM Prescribing in a Vacuum 11 ACO needs to include Community Pharmacy in the plan. Accountable Care Organization Pharmacy/ Health Information Exchange Community Pharmacy MTM Hospital Home Care SNF Comprehensive Transistions Med Rec with MTM Alligned, Efficient, Incentive- Driven Model Clinics Coordinated Prescribing 12 4
5 Accountable Care Organizations - Do you understand the ACO in your area? 13 Hennepin Experience ONE year pilot project with Minnesota Medicaid." Patients," - 46% had 10 meds or more" - HCMC Pharmacy provided: " - Extensive med rec in hospital" - Coordinated medications on discharge" - MTM follow-up within 5 days of discharge" - No involvement with PBM or cost control activities" 14 Hennepin Experience - Outcomes Admission rate reduced by 42%" Emergency Room visits decreased by 37% " - Reduced total cost of care by $2500 per person!! 15 5
6 Accountable Care Organizations - Do you continue providing services as a feefor-service? No Risk - Is your Community Pharmacy equipped to be at RISK with your ACO? 16 Behind the scenes of the ACO Pharmacy needs to know about the ACO Key Facts - How many members are in the ACO? - What is the member utilization of prescription benefits? - What is the average prescription cost PMPM? - What is the generic dispensing rate? - Will the community pharmacy be allowed to dispense specialty drugs? Are there special rates/ considerations 17 - Behind the scenes of the ACO Pharmacy needs to know how the ACO fits - How many current ACO members use my pharmacy? - What is my cost to fill those prescriptions? - What is the current revenue for this business? - What services can I provide to provide additional value? 18 6
7 Fee-for-Service or At-Risk Honestly, ACO models are not ready for Community pharmacy to be at risk. - Information is controlled by PBM industry. How do we change the model? Do we want to? 19 Incorporate Community Pharmacy Services into the ACO What services can you provide that will improve your value to the ACO? - As the most visible health professional, Pharmacy has opportunities" - Increase involvement in High Risk areas." - Diabetes" - Anticoagulation" - Asthma" " 20 Medical Record Pharmacy needs write access to the medical record" 21 7
8 As ACO s Mature Total cost of care will incorporate community pharmacy performance. - Top performers will gain volume and market share! 22 Accountable Care Organizations - Does the ACO understand the value your Community Pharmacy can provide? 23 What is your Next Step? Is the ACO for You?! 24 8
9 References "Medicare "Accountable Care Organizations" Shared Savings Program - New Section 1899 of Title XVIII, Preliminary Questions & Answers". Centers for Medicare and Medicaid Services. Retrieved January 10, Gold J. Accountable Care Organizations, Explained. Kaiser Health News, NPR. Jan 18, %E2%80%9Caccountable-care-organization%E2%80%9D/ - implementing-acos-a-top-challenge-for-medical-groups-survey-finds.html 25 References - McClellan M, McKethan AN, Lewis JL, Roski J, Fisher ES (2010). A National Strategy to Put Accountable Care Into Practice. 29. pp. 982=990. doi: /hlthaff PMID Leavitt Partners, Growth and Dispersion of Accountable Care Organizations: June 2012 Update. - Yap D. Pharmacy to CMS: Explicitly include pharmacists in ACOs. American Pharmacists Association. - Stein M. Pharmacists Pursue Legislative, Contractual Strategies To Gain Key Role In ACOs. Daily News Updates from Inside Health Policy. - CMS/Inside-CMS-03/01/2012/menu-id-316.html. Accessed March 1, 2012." - Pharmacists as Vital Members of Accountable Care Organizations. Academy of Managed Care Pharmacy. Accessed February 16, 2012." - ACO Success Depends on Optimal Medication Management. The Pink Sheet. July 23, "Health Policy Brief: Accountable Care Organizations," Health Affairs, July 27, Berwick DM. Making good on ACOs promise the final rule for the Medicare Shared Savings Program. N Engl J Med 2011; 365:
RIH Transitions of Care Collaboration with Coastal Medical To Improve Transitions for Patients Discharged Hospital To Home
RIH Transitions of Care Collaboration with Coastal Medical To Improve Transitions for Patients Discharged Hospital To Home Sergio Petrillo, PharmD Clinical Pharmacist Specialist, Rhode Island Hospital
Accountable Care Organizations and Patient-Centered Medical Homes
Emerging Topics in Healthcare Reform Accountable Care Organizations and Patient-Centered Medical Homes Janssen Pharmaceuticals, Inc. Accountable Care Organizations and Patient-Centered Medical Homes The
Reconciling the Differences. Karen Lippett B.Sc.Phm Humber River Regional Hospital Renal Dialysis Unit
Reconciling the Differences Karen Lippett B.Sc.Phm Humber River Regional Hospital Renal Dialysis Unit Objectives 1. Review the medication discharge counselling process in the renal dialysis program 2.
Second Annual Florida 2008 Electronic Prescribing Report
Second Annual Florida 2008 Electronic Prescribing Report FLORIDA CENTER FOR HEALTH INFORMATION AND POLICY ANALYSIS AGENCY FOR HEALTH CARE ADMINISTRATION JANUARY 2009 Better Health Care for All Floridians
Breakfast symposium: From hospital to home - the focus on the patient
Breakfast symposium: From hospital to home - the focus on the patient Nadya Hamedi DARZI Fellow UCLPartners and Barts Health NHS Trust in collaboration with North Central London Local Pharmaceutical Committee
ORAL ANTICOAGULANTS - RIVAROXABAN (XARELTO) FOR ATRIAL FIBRILLATION
ORAL ANTICOAGULANTS - RIVAROXABAN (XARELTO) FOR ATRIAL FIBRILLATION Information Leaflet Your Health. Our Priority. Page 2 of 6 What Are Anticoagulants And What Do They Do? This information leaflet has
Accountable Care Organizations and Health Reform
Accountable Care Organizations and Health Reform Country: USA Partner Institute: Johns Hopkins Bloomberg School of Public Health, Department of Health Policy and Management Survey no: (16)2010 Author(s):
THE AFFORDABLE CARE ACT: KEY POINTS FOR PHARMACISTS. Sarah M. Smith, Pharm.D., BCACP Douglas H. Kay Symposium June 11, 2014
THE AFFORDABLE CARE ACT: KEY POINTS FOR PHARMACISTS Sarah M. Smith, Pharm.D., BCACP Douglas H. Kay Symposium June 11, 2014 Objectives 1. Summarize the major changes the Affordable Care Act (ACA) will have
Ernest Boyd, R.Ph., MBA Executive Director Ohio Pharmacists Association
Ernest Boyd, R.Ph., MBA Executive Director Ohio Pharmacists Association CDC s Guide for Pharmacist Partnership for Public Health Brief overview of Pharmacists All graduate with 6 to 8 year Doctor of Pharmacy
Re: CMS-1345-P; Medicare Program; Medicare Shared Savings Program: Accountable Care Organizations; Proposed Rule
Department of Health and Human Services Attention: CMS 1345 P P.O. Box 8013, Baltimore, MD 21244 8013 Re: CMS-1345-P; Medicare Program; Medicare Shared Savings Program: Accountable Care Organizations;
Formulary Management
Formulary Management Formulary management is an integrated patient care process which enables physicians, pharmacists and other health care professionals to work together to promote clinically sound, cost-effective
What You Need to KnowWhen Taking Anticoagulation Medicine
What You Need to KnowWhen Taking Anticoagulation Medicine What are anticoagulant medicines? Anticoagulant medicines are a group of medicines that inhibit blood clotting, helping to prevent blood clots.
First Health Part D Value Plus (PDP) offered by First Health Life & Health Insurance Company
First Health Part D Value Plus (PDP) offered by First Health Life & Health Insurance Company Annual Notice of Changes for 2016 You are currently enrolled as a member of First Health Part D Value Plus (PDP).
Introduction. Background to this event. Raising awareness 09/11/2015
Introduction Primary Care Medicines Governance HSCB Background to this event New class of medicines Availability of training Increasing volume of prescriptions Reports of medication incidents Raising awareness
Health Care System. Troyen Brennan, M.D., M.P.H. Executive Vice President & Chief Medical Officer
Creating a More Connected Health Care System Troyen Brennan, M.D., M.P.H. Executive Vice President & Chief Medical Officer Agenda Our Role in the Changing Health Care System CVS/minuteclinic: Growth and
About NEHI: NEHI is a national health policy institute focused on enabling innovation to improve health care quality and lower health care costs.
1 Aaron McKethan PhD (amckethan@rxante.com) About NEHI: NEHI is a national health policy institute focused on enabling innovation to improve health care quality and lower health care costs. In partnership
Health Division Contact: Brendan Krause, 202/624-5367 or bkrause@nga.org August 2004
Issue Brief Health Division Contact: Brendan Krause, 202/624-5367 or bkrause@nga.org August 2004 State Purchasing Pools for Prescription Drugs: What s Happening and How Do They Work? Summary States are
Stroke/VTE Quality Measure Build for Meaningful Use Stage 1
Stroke/VTE Quality Measure Build for Meaningful Use Stage 1 Presented by Susan Haviland, BSN RN Senior Consult, Santa Rosa Consulting Meaningful Use Quality Measures Centers for Medicare and Medicaid Services
ACCOUNTABLE CARE ORGANIZATIONS: AN OPPORTUNITY FOR COMMUNITY PHARMACISTS?
ACCOUNTABLE CARE ORGANIZATIONS: AN OPPORTUNITY FOR COMMUNITY PHARMACISTS? PENNSYLVANIA PHARMACIST ASSOCIATION MID-YEAR CONFERENCE FEBRUARY 20, 2015 Christine M. O Leary, PharmD, BCPS DISCLOSURES Christine
Electronic Health Record (EHR) Incentive Program. Stage 2 Final Rule Update Part 2
Office of Medical Assistance Programs Electronic Health Record (EHR) Incentive Program Stage 2 Final Rule Update Part 2 November 7, 2012 Medical Assistance HIT Initiative 1 Office of Medical Assistance
Accountable Care Organizations: What Are They and Why Should I Care?
Accountable Care Organizations: What Are They and Why Should I Care? Adrienne Green, MD Associate Chief Medical Officer, UCSF Medical Center Ami Parekh, MD, JD Med. Director, Health System Innovation,
ORAL ANTICOAGULANTS - RIVAROXABAN (XARELTO) FOR DEEP VEIN THROMBOSIS (DVT)
ORAL ANTICOAGULANTS - RIVAROXABAN (XARELTO) FOR DEEP VEIN THROMBOSIS (DVT) Information Leaflet Your Health. Our Priority. Page 2 of 6 What Are Anticoagulants And What Do They Do? This information leaflet
Summary of Benefits. (PDP), Blue MedicareRx Plus SM. (PDP) and Blue MedicareRx Premier SM
Summary of Benefits for SM, Plus SM and Premier SM Available in Maine and New Hampshire A -approved Part D sponsor. Anthem Insurance Companies, Inc. (AICI) is the legal entity who has contracted with the
Adverse Drug Events and Medication Safety: Diabetes Agents and Hypoglycemia
Adverse Drug Events and Medication Safety: Diabetes Agents and Hypoglycemia Date: October 20, 2015 Presented by Mike Crooks, PharmD., PCMH-CCE Pharmacy Interventions, Technical Lead 11/9/2015 1 Objectives:
Technician Learning Objectives 3/25/2014. Pharmacy Practice Changes in ACA Accountable Care Organizations
Pharmacy Practice Changes in ACA Accountable Care Organizations Avani S. Desai, PharmD & Emory S. Martin PharmD Sunday, April 12, 2014 9:05 10:05 am Pharmacist Learning Objectives At the conclusion of
Health IT: Provider s Issues
Health IT: Provider s Issues Presented by Paul Uhrig SureScripts 2008 FTC Public Workshop April 24, 2008 1 SureScripts Mission: Improve the prescribing process. Industry owned LLC formed by the pharmacy
Introduction to Medication Management Systems, Inc. Comprehensive Medication Therapy Management Solutions
Introduction to Medication Management Systems, Inc. Comprehensive Medication Therapy Management Solutions Vision Medication Management Systems, Inc. (MMS) envisions a health care system in which all patients
Utilizing Pharmacy Technicians for Medication Reconciliation. Kristy Malacos, MS, CPhT Magruder Hospital Port Clinton, OH Pharmacy Systems, Inc.
Utilizing Pharmacy Technicians for Medication Reconciliation Kristy Malacos, MS, CPhT Magruder Hospital Port Clinton, OH Pharmacy Systems, Inc. Magruder Hospital Located on the shores of Lake Erie in Port
Medicare Prescription Drug Coverage: How to File a Complaint, Coverage Determination, or Appeal
CENTERS FOR MEDICARE & MEDICAID SERVICES Medicare Prescription Drug Coverage: How to File a Complaint, Coverage Determination, or Appeal Medicare offers insurance coverage for prescription drugs through
ACCOUNTABLE CARE ANALYTICS: DEVELOPING A TRUSTED 360 DEGREE VIEW OF THE PATIENT
ACCOUNTABLE CARE ANALYTICS: DEVELOPING A TRUSTED 360 DEGREE VIEW OF THE PATIENT Accountable Care Analytics: Developing a Trusted 360 Degree View of the Patient Introduction Recent federal regulations have
PROTOCOL TITLE: Ambulatory Initiation and Management of Warfarin for Adults
PROTOCOL NUMBER: 7 PROTOCOL TITLE: Ambulatory Initiation and Management of Warfarin for Adults THIS PROTOCOL APPLIES TO: UW Health Clinics: all adult outpatients with an active order for warfarin TARGET
Annual Notice of Changes for 2015
First Health Part D Value Plus (PDP) Plan offered by First Health Life & Health Insurance Company Annual Notice of Changes for 2015 You are currently enrolled as a member of First Health Part D Essentials
Meaningful Use Stage 2: What s Next?
Meaningful Use Stage 2: What s Next? Stage 2 Proposed Rule Lisa Hays, Program Manager Sue Shumate, Implementation Specialist MO-12-02-REC April 2012 Slides adapted from Robert Anthony, CMS Steve Posnack
Alert. Patient safety alert. Actions that can make anticoagulant therapy safer. 28 March 2007. Action for the NHS and the independent sector
Patient safety alert 18 Alert 28 March 2007 Immediate action Action Update Information request Ref: NPSA/2007/18 4 Actions that can make anticoagulant therapy safer Anticoagulants are one of the classes
How To Treat Aneuricaagulation
Speaker Introduction Jessica Wilhoite, PharmD, BCACP Doctor of Pharmacy: Purdue University Postgraduate Residency Training: PGY1 Pharmacy Practice St. Vincent Hospital PGY2 Ambulatory Care St. Vincent
Anticoagulants for stroke prevention in atrial fibrillation Patient frequently asked questions
Anticoagulants for stroke prevention in atrial fibrillation Patient frequently asked questions What is atrial fibrillation?...2 What are dabigatran, rivaroxaban and apixaban and what are they used for?...2
Faculty Disclosure. Pharmacist Learning Objectives. Pharmacy e-hit: The Future of Pharmacy and Patient Care
Pharmacy e-hit: The Future of Pharmacy and Patient Care 1 Faculty Disclosure Ms Spiro has no actual or potential conflicts of interest associated with this presentation. 2 Pharmacist Learning Objectives
Summary of benefits. 2009 idaho, utah. Health Net orange prescription drug plan
Health Net orange prescription drug plan Summary of benefits 2009 idaho, utah Benefits effective January 1, 2009 (S5678-064) PDP Option 1 (S5678-063) PDP Value Option 2 Section I INTRODUCTION TO SUMMARY
The Medical Neighborhood: HIT Enablement of Medication-Related Care Coordination
The Medical Neighborhood: HIT Enablement of Medication-Related Care Coordination 1 Collaborative Members Founding Organizations 9 Professional Pharmacy Associations Represents over 250K members in all
Medication Homes Play Vital Role in the ACO
Medication Homes Play Vital Role in the ACO About PharmMD PharmMD offers a comprehensive MTM program that exceeds the requirements for MTM set forth by CMS and pharmacy professional organizations. Clients
c. determine the factors that will facilitate/limit physician utilization of pharmacists for medication management services.
Consumer, Physician, and Payer Perspectives on Primary Care Medication Management Services with a Shared Resource Pharmacists Network Marie Smith, PharmD and Michlle Breland, PhD University of Connecticut,
February 21, 2011. Regina Benjamin, MD, MBA U.S. Surgeon General Office of the Surgeon General 5600 Fishers Lane, Room 18-66 Rockville, MD 20857
February 21, 2011 Regina Benjamin, MD, MBA U.S. Surgeon General Office of the Surgeon General 5600 Fishers Lane, Room 18-66 Rockville, MD 20857 Dear Dr. Benjamin: I want to take this opportunity to express
Patient frequently asked questions
Patient frequently asked questions What is atrial fibrillation?...2 What are dabigatran and rivaroxaban and what are they used for?...2 Which is better, dabigatran or rivaroxaban?...2 For patients with
CMS-CMMI Releases Enhanced Medication Therapy Management (MTM) Model Test Beginning in January 2017
October 5, 2015 www.amcp.org CMS-CMMI Releases Enhanced Medication Therapy Management (MTM) Model Test Beginning in January 2017 Pursuant to a memorandum issued on September 28, 2015, the Centers for Medicare
Meaningful Use Criteria for Eligible Hospitals and Eligible Professionals (EPs)
Meaningful Use Criteria for Eligible and Eligible Professionals (EPs) Under the Electronic Health Record (EHR) meaningful use final rules established by the Centers for Medicare and Medicaid Services (CMS),
Safety indicators for inpatient and outpatient oral anticoagulant care
Safety indicators for inpatient and outpatient oral anticoagulant care 1 Recommendations from the British Committee for Standards in Haematology (BCSH) & National Patient Safety Agency (NPSA) Address for
First Health Part D Prescription Drug Plan (PDP) S5768 S5674
2011 SUMMARY OF BENEFITS First Health Part D Prescription Drug Plan (PDP) S5768 S5674 Y0022_2011_1001_046_25 CMS Approval Date: 09/23/2010 FH11SB25 Section I Introduction to Summary of Benefits Thank you
List of covered prescription drugs (formulary)
Revised July 2014 How Medicare Prescription Drug Plans and Medicare Advantage Plans with Prescription Drug Coverage (MA-PDs) Use Pharmacies, Formularies, & Common Coverage Rules Each Medicare Prescription
ACO Definition Cont d 11/15/15. What is an Accountable Care Organization (ACO) Michelle S. McOmber, MBA, CAE CEO, Utah Medical Association
Michelle S. McOmber, MBA, CAE CEO, Utah Medical Association What is an Accountable Care Organization (ACO) Accountable Care Organizations were created through the Affordable Care Act. Definition: An ACO
Pharmacy and the Medicaid Accountable Care Organization
RCCO Pilot Project CDC Grant Increase engagement of non-physician team members (ie., pharmacists) in Hypertension (HTN) and Diabetes Mellitus (DM) management in health care systems; Increase the proportion
5557 FAQs & Definitions
5557 FAQs & Definitions These Questions and Answers are intended to present information that has been acquired as part of the discovery process and provides necessary context for the Policy Directives
Insight Into Evolving Payment and Delivery Models
Insight Into Evolving Payment and Delivery Models Overview Objectives Provide an overview of Accountable Care Organization (ACO)-like payment and delivery models Demonstrate Genentech s commitment to patient
First Name Middle Initial Last Name. Home Address. City State Zip. E-mail Date of Birth Sex: Male Female
800.334.1330 254.773.1330 fax 254.774.7652 4912 Midway Drive Post Office Box 6130 Temple, TX 76503-6130 www.carehealthplan.com A. PLEASE INDICATE WHICH PLAN YOU WISH TO ENROLL IN: Plan #4000 - Supplement
2014 Prescription Drug Schedule Humana Medicare Employer Plan
2014 Prescription Drug Schedule Humana Medicare Employer Plan Option 98 City of Newport News Y0040_GHHHEF3HH14 SECTION I - INTRODUCTION TO SUMMARY OF BENEFITS Thank you for your interest in the Humana
Essential Reading Accountable Care Organisations (ACOs) A Reading List produced by QIPP Right Care Nicola Pearce-Smith September 2011
Essential Reading SEPTEMBER 2011 Accountable Care Organisations (ACOs) A Reading List produced by QIPP Right Care Nicola Pearce-Smith September 2011 Right Care Essential Reading: September 2011 1 Introduction
COLORADO DEPARTMENT OF HEALTH CARE POLICY AND FINANCING
COLORADO DEPARTMENT OF HEALTH CARE POLICY AND FINANCING LEGISLATIVE REQUEST FOR INFORMATION # 4 COMPREHENSIVE MEDICATION MANAGEMENT NOVEMBER 1, 2013 Legislative Request for Information #4 states: The Department
Pharmacy Benefit Managers: What we do
Pharmacy Benefit Managers: What we do Steve Boekenoogen, Pharm.D. Poulsbo, WA & San Diego CA Manager, Clinical Services & Integration MedImpact Healthcare Systems, Inc Dan Danielson, M.S., RPh. Lynnwood,
2013 SUMMARY OF BENEFITS
22222 2013 SUMMARY OF BENEFITS Plus Prescription Drug Plans S5670 S5768 Y0022_PDP_2013_S5670_036_S5768_009_S5768_129SBa Accepted FH13SB06VP2 22 SECTION I INTRODUCTION TO SUMMARY OF BENEFITS Thank you for
Soundpath Medicare Advantage Plan Information
Soundpath Medicare Advantage Plan Information Thank you for your interest in the Soundpath Health Medicare Advantage plan. Below are links to the items which are part of the Enrollment Packet you would
Statement Of. The National Association of Chain Drug Stores. For. U.S. Senate Committee On Armed Services. Personnel Subcommittee.
Statement Of The National Association of Chain Drug Stores For U.S. Senate Committee On Armed Services Personnel Subcommittee Hearing on FY2014 Budget April 17, 2012 2:00p.m. Russell Senate Office Building
Reducing Adverse Drug Events With Anti Coagulation Clinics. McFarland Clinic. McFarland Protime Clinic 09/05/12
Reducing Adverse Drug Events With Anti Coagulation Clinics Dr. Donald Skinner, MD McFarland Clinic 182 Physicians (149 Shareholders) 40 Mid Level Providers 13 Administrators/Executive Directors 1,200 Support
Statement Of. The National Association of Chain Drug Stores. For. U.S. Senate Special Committee on Aging. Hearing on:
Statement Of The National Association of Chain Drug Stores For U.S. Senate Special Committee on Aging Hearing on: 10 Years Later: A Look at the Medicare Prescription Drug Program 2:30 p.m. 366 Dirksen
Reimbursement for Clinical Pharmacy Services: Is There a Role for Facility Billing?
Reimbursement for Clinical Pharmacy Services: Is There a Role for Facility Billing? Edith A. Nutescu, Pharm.D., FCCP Laura D. Roller, Pharm.D., BCPS, CACP Current Billing Models: Clinical Pharmacy Services
Outpatient Anticoagulation Treatment Packet
Emergency / Pharmacy Services Outpatient Anticoagulation Treatment Packet Check when complete (If indicated): Primary Care Provider Follow Referral to Franciscan Transitional Clinic (if no primary care
MAPD-SNP Contract Numbers: H5852; H3132
Policy and Procedure No: 93608 PHP Transition Process Title: Part D Transition Process Department: Pharmacy Services, Managed Care Effective Date: 1/1/2006 Supercedes Policy No: PH 8.0 Reviewed/Revised
7/25/2015. Disclosure(s) Prescription for the Future: Pharmacists Influencing Positive Health Outcomes. Clinical Practice.
49th Annual Meeting Prescription for the Future: Pharmacists Influencing Positive Health Outcomes Daniel E. Buffington, PharmD, MBA, FAPhA Clinical Pharmacology Services, Inc Tampa, FL Disclosure(s) Daniel
2013 SUMMARY OF BENEFITS
2013 SUMMARY OF BENEFITS Plus Prescription Drug Plans S5670 S5768 Y0022_PDP_2013_S5670_138_S5768_119_S5768_150_SBb Accepted FH13SB935 SECTION I INTRODUCTION TO SUMMARY OF BENEFITS Thank you for your interest
Accountable Care for Pharmacy Executives
Accountable Care for Pharmacy Executives A Prescription for Change L. David Harlow III RPh Director of Pharmacy Carilion Clinic New River Valley Medial Center Objectives At the completion of this knowledge
STATEMENT OF TIM GRONNIGER DIRECTOR OF DELIVERY SYSTEM REFORM CENTERS FOR MEDICARE & MEDICAID SERVICES
STATEMENT OF TIM GRONNIGER DIRECTOR OF DELIVERY SYSTEM REFORM CENTERS FOR MEDICARE & MEDICAID SERVICES ON EXAMINING THE MEDICARE PART D MEDICATION THERAPY MANAGEMENT PROGRAM BEFORE THE U.S. HOUSE COMMITTEE
Advanced Pharmacy Technician Practice Model Case Study
Advanced Pharmacy Technician Practice Model Case Study Froedtert Hospital, Milwaukee, Wisconsin Discharge Pharmacy Technician Lindsey Clark, Pharm.D. PGY2 Health-System Pharmacy Administration Resident
HITECH Act Update: An Overview of the Medicare and Medicaid EHR Incentive Programs Regulations
HITECH Act Update: An Overview of the Medicare and Medicaid EHR Incentive Programs Regulations The Health Information Technology for Economic and Clinical Health Act (HITECH Act) was enacted as part of
Inpatient Anticoagulation Safety. To provide safe and effective anticoagulation therapy through a collaborative approach.
Inpatient Anticoagulation Safety Purpose: Policy: To provide safe and effective anticoagulation therapy through a collaborative approach. Upon the written order of a physician, Heparin, Low Molecular Weight
Federal Health Care Reform: Implications for Hospital and Physician partnerships. Walter Kopp Medical Management Services
Federal Health Care Reform: Implications for Hospital and Physician partnerships Walter Kopp Medical Management Services Outline Overview of federal health reform legislation Implications for Care delivery
HEALTH REFORM AND THE PATIENT-CENTERED MEDICAL HOME: Policy Provisions and Expectations of the Patient Protection and Affordable Care Act
Safety Net Medical Home Initiative HEALTH REFORM AND THE PATIENT-CENTERED MEDICAL HOME: Policy Provisions and Expectations of the Patient Protection and Affordable Care Act Policy Brief Issue 2 Introduction
A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation
Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation PATIENT EDUCATION GUIDE What is atrial fibrillation? Atrial fibrillation
18% Role of Pharmacist-Provided Medication Reviews in Workers Compensation Claims Management. Introduction. Role of the Pharmacist
Role of Pharmacist-Provided Medication Reviews in Workers Compensation Claims Management Benjamin Link, PharmD, RPh Introduction According to information from the National Council on Compensation Insurance
Warfarin therapy for stroke patients with atrial fibrillation
Warfarin therapy for stroke patients with atrial fibrillation Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm
Welcome! Medicare Advantage. Elderplan Advantage Institutional Special Needs Plan
Elderplan Advantage Institutional Special Needs Plan 1 Welcome! Goals for today: To give you an overview of Medicare Advantage Works To give you a sense of the role of ISNP in an SNF To provide a description
HealthPartners: Triple Aim Approach to ACO Development
HealthPartners: Triple Aim Approach to ACO Development Brian Rank, MD Medical Director, HealthPartners Medical Group October 27, 2010 HealthPartners Integrated Care and Financing System 10,300 employees
Florida MCA Client Newsletter Fall 2013
A semi-annual educational newsletter dedicated to our clients using the Florida Managed Care Arrangement. FL MCA COMPLIANCE HIGHLIGHTS SEMI-ANNUAL NETWORK REVIEW JUN 2013 & NOVEMBER - ACCESS & AVAILABILITY
Paramount Elite Standard Medical and Drug (HMO) offered by Paramount Care, Inc.
Paramount Elite Standard Medical and Drug (HMO) offered by Paramount Care, Inc. Annual Notice of Changes for 2016 You are currently enrolled as a member of Paramount Elite Standard Medical and Drug (HMO).
Atrial fibrillation (non-valvular) and reducing the risk of a stroke Management Options Brief Decision Aid
Atrial fibrillation (non-valvular) and reducing the risk of a stroke Management Options Brief Decision Aid Atrial fibrillation (AF) increases your risk of having a stroke (a blood clot in the brain). From
Care and EHR Integration Connecting Physical and Behavioral Health in the EHR. Tarzana Treatment Centers Integrated Healthcare
Care and EHR Integration Connecting Physical and Behavioral Health in the EHR Tarzana Treatment Centers Integrated Healthcare Outline of Presentation Why Integrate Care? Integrated Care at Tarzana Treatment
How Do Key Stakeholders View Transparency?
How Do Key Stakeholders View Transparency? Given the clear need for transparency, and the gaps towards achieving the level needed to create full accountability to drive lower costs and improved quality
Building a Specialty Pharmacy Business. Kyle Skiermont, PharmD Director of Specialty/Infusion Operation Fairview Pharmacy Services
Building a Specialty Pharmacy Business Kyle Skiermont, PharmD Director of Specialty/Infusion Operation Fairview Pharmacy Services Overview Agenda Brief overview of Fairview Barriers for hospital/health
The Future of Pharmacy??? M. Lynn Crismon, Pharm.D. Dean Doluisio Chair, & Behrens Professor College of Pharmacy The University of Texas at Austin
The Future of Pharmacy??? M. Lynn Crismon, Pharm.D. Dean Doluisio Chair, & Behrens Professor College of Pharmacy The University of Texas at Austin February 25, 2011 Disclosure During the past 12 months,
Real-time Pre and Post Claim Edits: Improve Reimbursement, Compliance and Safety
Real-time Pre and Post Claim Edits: Improve Reimbursement, Compliance and Safety An ESI Healthcare Business Solutions White Paper by Thomas Renshaw R.Ph. Introduction Outpatient pharmacies submitting claims
INTRO TO THE MICHIGAN PIONEER ACO 101: THE BASICS. Karen Unholz, RN, BSN
INTRO TO THE MICHIGAN PIONEER ACO 101: THE BASICS Karen Unholz, RN, BSN Origins of the Accountable Care Organization ACOs originated from the Patient Protection and Affordable Care Act (Healthcare Reform)
HEALTHCARE REFORM OCTOBER 2012
HEALTHCARE REFORM Tracking ACO Growth Nationally OCTOBER 2012 The enclosed slides are intended to provide you with a snapshot of how private sector accountable care organizations (ACOs) have formed since
An Overview of Meaningful Use: FAQs
An Overview of Meaningful Use: FAQs On Feb. 17, 2009, President Obama signed the American Recovery and Reinvestment Act of 2009 (ARRA) into law. This new law includes provisions (known as the HITECH Act)
Updates to the Alberta Human Services Drug Benefit Supplement
Updates to the Alberta Human Services Drug Benefit Supplement Effective January 1, 2016 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone
QUM and Continuity of Care A Prescribed Medicines Services and Programs
Community Pharmacy Roadmap Program Development Template Program/Service: Quadrant: 1. Program/Service Description QUM and Continuity of Care A Prescribed Medicines Services and Programs a) Background The
Using Medicare s Website to Choose a Medicare-Approved Drug Plan 2016. Prepared by Senior PharmAssist (rev 10.07.2015)
TIPS AND HINTS: Using Medicare s Website to Choose a Medicare-Approved Drug Plan 2016 Prepared by Senior PharmAssist (rev 10.07.2015) IT PAYS TO COMPARE. The plan that was the cheapest for you in 2015
Are You a Hospital Inpatient or Outpatient?
Are You a Hospital Inpatient or Outpatient? If You Have Medicare Ask! Revised May 2014 Did you know that even if you stay in a hospital overnight, you might still be considered an outpatient? Your hospital
For a Healthier America: Reducing Prescription Drug Misuse and Abuse
For a Healthier America: Reducing Prescription Drug Misuse and Abuse The misuse and abuse of prescription medicines is a growing public health problem. In addition to the tragic toll on families and communities,
Applying ACO Principles to a Pediatric Population UH Rainbow Care Connection: Transforming Pediatric Ambulatory Care with a Physician Extension Team
Applying ACO Principles to a Pediatric Population UH Rainbow Care Connection: Transforming Pediatric Ambulatory Care with a Physician Extension Team Ethan Chernin, MBA Director 1 Objectives Understand
A PATIENT S GUIDE TO DEEP VEIN THROMBOSIS TREATMENT
A PATIENT S GUIDE TO DEEP VEIN THROMBOSIS TREATMENT This medicine is subject to additional monitoring. This will allow quick identification of new safety information. If you get any side effects, talk
Annual Notice of Changes for 2016
Healthy Advantage Plus HMO offered by Molina Healthcare of Utah Annual Notice of Changes for 2016 You are currently enrolled as a member of Healthy Advantage Plus HMO. Next year, there will be some changes
Lydia Klinger Director, Ryan White & HIV Clinical Service Programs Virginia Commonwealth University. Mark Loafman MD, MPH
Lydia Klinger Director, Ryan White & HIV Clinical Service Programs Virginia Commonwealth University Mark Loafman MD, MPH Chair, Family and Community Medicine, Cook County Health and Hospitals System Lead,